Greiner Bio-One North America, Inc.: Medical Device Recall in 2016 - (Recall #: Z-1923-2016)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2016.

Data Source: FDA.

Product Description:

4 ml FX Sodium Fluoride/Potassium Oxalate tube, Ref 454297 VACUETTE Glycolytic Inhibitor Tubes contain an antiglycolytic agent, sodium fluoride, and an anticoagulant, potassium oxalate. The product is suitable for the analysis of blood glucose and lactate

Product Classification:

Class II

Date Initiated: April 26, 2016

Date Posted: June 15, 2016

Recall Number: Z-1923-2016

Event ID: 74002

Reason for Recall:

The 4 ml FX Sodium Fluoride/Potassium Oxalate tube may have no or low additive (sodium fluoride and potassium oxalate), which can effect analytical results for glucose and lactate.

Status: Terminated

Product Quantity: 250,800 pieces (209 cases)

Code Information:

Lot A151137L

Distribution Pattern:

Nationwide Distribution to CA, FL, IL, KY, NY, PA, VA and Puerto Rico

Voluntary or Mandated:

Voluntary: Firm initiated